Results 111 to 120 of about 5,684 (155)

LVH-Voltage Discordance and Myocardial Dysfunction in Wild-Type Transthyretin Cardiomyopathy: A Prospective Cohort Study. [PDF]

Echocardiography
Bahadır N, Osman Şeker O, Dereli S.
europepmc   +1 more source

Clinical Impact of Diagnostic Delay by Red Flags Assessment in Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Adv
Iseppi M, Moretti M, Capovilla TM, Zaro E, Barbati G, Bonvicini E, Morat F, Marini M, Bonmassari R, Sinagra G, Merlo M, Porcari A.   +11 more
europepmc   +1 more source

Gene silencing versus protein stabilization in transthyretin amyloid cardiomyopathy: contextualizing the HELIOS-B results and the road to precision agent selection. [PDF]

Ann Med Surg (Lond)
Khan SA, Ali T, Ul Haque MS, Qamar MA.
europepmc   +1 more source

The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CM. [PDF]

JACC CardioOncol
Witteles RM.
europepmc   +1 more source

Association between baseline left ventricular end-systolic diameter and one-year troponin response to tafamidis in transthyretin cardiac amyloidosis. [PDF]

Int J Cardiol Heart Vasc
Morishita K, Amiya E, Ishida J, Hatano M, Nakanishi K, Takeda N.   +5 more
europepmc   +1 more source

Monitoring the Electrical Phenotype of Transthyretin Amyloid Cardiomyopathy in the Era of Disease-Modifying Therapy. [PDF]

Circ Rep
Yonezu K, Kondo H, Takahashi N.
europepmc   +1 more source

Transthyretin Amyloidosis Due to a Rare TTR Val142del Deletion With Relatively Early Clinical Manifestations. [PDF]

JACC Case Rep
Espinoza Romero C, De Paula Morales K, Espirito Santo C, Dos Santos Ferreira G, Silva Martins A, Kerges Bueno BV, Fernandes F.   +6 more
europepmc   +1 more source

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Heart Fail
Testani JM, Judge DP, Borlaug BA, Cherney D, Cox ZL, Gillmore JD, Lewis JB, Adler SH, Cao X, Castaño A, Fox JC, Katz L, Mathur V, Xiong K, Butler J, Masri A.   +15 more
europepmc   +1 more source